BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 21243810)

  • 21. Characterization of cervical biopsies of women with HIV and HPV co-infection using p16
    Kremer WW; Vink FJ; van Zummeren M; Dreyer G; Rozendaal L; Doorbar J; Bleeker MCG; Meijer CJLM
    Mod Pathol; 2020 Oct; 33(10):1968-1978. PubMed ID: 32249820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exposure to tobacco smoke measured by urinary nicotine metabolites increases risk of p16/Ki-67 co-expression and high-grade cervical neoplasia in HPV positive women: A two year prospective study.
    White CM; Bakhiet S; Bates M; Ruttle C; Pilkington LJ; Keegan H; O'Toole SA; Sharp L; O'Kelly R; Tewari P; Flannelly G; Martin CM; O'Leary JJ;
    Cancer Epidemiol; 2020 Oct; 68():101793. PubMed ID: 32841926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL.
    Possati-Resende JC; Fregnani JH; Kerr LM; Mauad EC; Longatto-Filho A; Scapulatempo-Neto C
    PLoS One; 2015; 10(7):e0134445. PubMed ID: 26230097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p16INK4A immunoexpression and HPV in situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial neoplasia.
    Kalof AN; Evans MF; Simmons-Arnold L; Beatty BG; Cooper K
    Am J Surg Pathol; 2005 May; 29(5):674-9. PubMed ID: 15832093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.
    Wentzensen N; Schwartz L; Zuna RE; Smith K; Mathews C; Gold MA; Allen RA; Zhang R; Dunn ST; Walker JL; Schiffman M
    Clin Cancer Res; 2012 Aug; 18(15):4154-62. PubMed ID: 22675168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1-2 lesions.
    Li Y; Liu J; Gong L; Sun X; Long W
    Virol J; 2019 Oct; 16(1):117. PubMed ID: 31619262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of p16, human papillomavirus capsid protein L1 and Ki-67 in cervical intraepithelial lesions: potential utility in diagnosis and prognosis.
    Alshenawy HA
    Pathol Res Pract; 2014 Dec; 210(12):916-21. PubMed ID: 25149503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of geminin, p16, and Ki67 in cervical intraepithelial neoplasm and normal tissues.
    Xing Y; Wang C; Wu J
    Medicine (Baltimore); 2017 Jun; 96(26):e7302. PubMed ID: 28658133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interlaboratory concordance of p16/Ki-67 dual-staining interpretation in HPV-positive women in a screening population.
    Benevolo M; Mancuso P; Allia E; Gustinucci D; Bulletti S; Cesarini E; Carozzi FM; Confortini M; Bisanzi S; Carlinfante G; Rubino T; Rollo F; Marchi N; Farruggio A; Pusiol T; Venturelli F; Giorgi Rossi P;
    Cancer Cytopathol; 2020 May; 128(5):323-332. PubMed ID: 32168431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
    Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Ki-67 proliferative index and absence of P16INK4 in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion.
    Kuo KT; Chang HC; Hsiao CH; Lin MC
    Br J Ophthalmol; 2006 Jul; 90(7):894-9. PubMed ID: 16540490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 33. Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.
    Petry KU; Schmidt D; Scherbring S; Luyten A; Reinecke-Lüthge A; Bergeron C; Kommoss F; Löning T; Ordi J; Regauer S; Ridder R
    Gynecol Oncol; 2011 Jun; 121(3):505-9. PubMed ID: 21420158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples.
    Nasioutziki M; Daniilidis A; Dinas K; Kyrgiou M; Valasoulis G; Loufopoulos PD; Paraskevaidis E; Loufopoulos A; Karakitsos P
    Int J Gynecol Cancer; 2011 Jan; 21(1):79-85. PubMed ID: 21330832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.
    Howitt BE; Nucci MR; Drapkin R; Crum CP; Hirsch MS
    Am J Surg Pathol; 2013 Jan; 37(1):89-97. PubMed ID: 23211296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Ovestad IT; Dalen I; Hansen E; Loge JL; Dybdahl BM; Dirdal MB; Moltu P; Berland JM
    Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p16/Ki-67 dual staining has a better accuracy than human papillomavirus (HPV) testing in women with abnormal cytology under 30 years old.
    Pirtea L; Secosan C; Margan M; Moleriu L; Balint O; Grigoras D; Sas I; Horhat F; Jianu A; Ilina R
    Bosn J Basic Med Sci; 2019 Nov; 19(4):336-341. PubMed ID: 29924960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of p16 (INK4a) and Ki-67 in relation to high-risk human papilloma viral load and residual disease after conization with positive margins.
    Song SH; Park HM; Eom DW; Lee JK; Lee NW; Kim AR; Hur JY; Lee KW; Park YK; Saw HS
    Int J Gynecol Cancer; 2007; 17(4):858-67. PubMed ID: 17367326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix.
    Kumar R; Mandal S; Arora P; Mala YM; Khurana N
    J Obstet Gynaecol; 2021 Jul; 41(5):785-790. PubMed ID: 33073644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ki-67 quantitative evaluation as a marker of cervical intraepithelial neoplasia and human papillomavirus infection.
    Mimica M; Tomić S; Kardum G; Hofman ID; Kaliterna V; Pejković L
    Int J Gynecol Cancer; 2010 Jan; 20(1):116-9. PubMed ID: 20130511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.